Combined inhibition of mTORC1 with temsirolimus and HER2 with neratinib: A phase I study in patients with metastatic HER2-amplified breast cancer Meeting Abstract

  


Authors: Gajria, D.; King, T. A.; Pannu, H.; Sakr, R.; Seidman, A. D.; Syldor, A.; Patil, S.; Maybody, M.; Norton, L.; Rosen, N.; Hudis, C.; Chandarlapaty, S.
Abstract Title: Combined inhibition of mTORC1 with temsirolimus and HER2 with neratinib: A phase I study in patients with metastatic HER2-amplified breast cancer
Meeting Title: 47th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 29
Issue: 15 Suppl.
Meeting Dates: 2011 Jun 3-7
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2011-05-20
Language: English
ACCESSION: WOS:000208880300077
DOI: 10.1200/jco.2011.29.15_suppl.574
PROVIDER: wos
Notes: Meeting Abstract: 574 -- Source: Wos
Altmetric
What is Altmetric?
Citation Impact
What is Dimensions Citation Badge?
BMJ Impact Analytics
MSK Authors
  1. Sujata Patil
    511 Patil
  2. Andrew D Seidman
    318 Seidman
  3. Clifford Hudis
    905 Hudis
  4. Larry Norton
    758 Norton
  5. Neal Rosen
    425 Rosen
  6. Harpreet Pannu
    22 Pannu
  7. Tari King
    186 King
  8. Majid Maybody
    98 Maybody
  9. Devika Gajria
    31 Gajria
  10. Sarat Chandarlapaty
    277 Chandarlapaty
  11. Rita Sakr
    61 Sakr
  12. Angemael Syldor
    7 Syldor
Related MSK Work